Retraction Note: A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level

Arch Gynecol Obstet. 2024 Feb;309(2):729. doi: 10.1007/s00404-023-07330-z.
No abstract available

Publication types

  • Retraction of Publication